CA 15-3 Levels in Non-Mammary Cancers
Author Information
Author(s): R. Colomer, A. Ruibal, J. Genollk, L. Salvador
Primary Institution: Valle de Hebrón Hospital
Hypothesis
Circulating CA 15-3 antigen levels might be useful in the differential diagnosis of the primary site of cancer.
Conclusion
CA 15-3 antigen levels can be elevated in various types of cancer, especially with distant metastases, but should not be used to determine the primary cancer site in metastatic cases.
Supporting Evidence
- Elevated CA 15-3 levels were observed in 70% of patients with metastatic ovarian cancer.
- Patients with distant metastases had significantly higher CA 15-3 levels than those with locoregional disease.
- CA 15-3 levels correlated with the extent of non-mammary malignant tumors.
Takeaway
CA 15-3 is a marker that can be found in the blood of cancer patients, especially those with advanced disease, but it doesn't help doctors figure out where the cancer started if it's spread.
Methodology
The study measured CA 15-3 levels in the serum of 500 patients with various non-mammary cancers and compared them with healthy controls.
Limitations
The study does not address all types of malignancies and factors affecting CA 15-3 levels in non-mammary cancers.
Participant Demographics
Participants ranged from 2 to 84 years old, with a mean age of 58.1 years; 208 were female and 292 were male.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website